Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hg and Se in Muscle and Liver of Blue Shark (Prionace glauca) from the Entrance of the Gulf of California: An Insight to the Potential Risk to Human Health.

Archives of environmental contamination and toxicology·2024
Same author

Bioaccumulation of cd and hg in Muscle of Juvenile Pacific Sharpnose Shark Rhizoprionodon longurio from the SE Gulf of California.

Bulletin of environmental contamination and toxicology·2022
Same author

First insight into plastics ingestion by fish in the Gulf of California, Mexico.

Marine pollution bulletin·2021
Same author

Mercury Levels in Fish for Human Consumption from the Southeast Gulf of California: Tissue Distribution and Health Risk Assessment.

Archives of environmental contamination and toxicology·2018
Same author

Seasonal changes of fish assemblages in a subtropical lagoon in the SE Gulf of California.

TheScientificWorldJournal·2014
Same author

PERICARDITIS IN SYSTEMIC DISEASES.

A listing of research in the cardiovascular field·2014

Related Experiment Video

Updated: Jun 18, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

THERAPY OF SEVERE RHEUMATIC CARDITIS. COMPARISON OF ADRENOCORTICAL STEROIDS AND ASPIRIN

G CZONICZER, F AMEZCUA, S PELARGONIO

    Circulation
    |June 1, 1964
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    ADRENAL CORTEX HORMONESASPIRINDRUG THERAPYHEART FAILURE, CONGESTIVEPENICILLINPERICARDITISRHEUMATIC HEART DISEASESTATISTICS

    More Related Videos

    Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
    07:35

    Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

    Published on: December 10, 2021

    Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
    09:53

    Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

    Published on: January 10, 2025

    Related Experiment Videos

    Last Updated: Jun 18, 2026

    Myocardial Infarction and Functional Outcome Assessment in Pigs
    12:03

    Myocardial Infarction and Functional Outcome Assessment in Pigs

    Published on: April 25, 2014

    Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
    07:35

    Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

    Published on: December 10, 2021

    Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
    09:53

    Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

    Published on: January 10, 2025